Indivior Pharmaceuticals (INDV) Interest Coverage Ratio (2024 - 2026)
Indivior Pharmaceuticals (INDV) posted quarterly Interest Coverage Ratio of 9.79 for Q1 2026, up 77.92% year-over-year from 5.5 in Q1 2025, and down 27.51% quarter-over-quarter from 13.5 in Q4 2025.
Indivior Pharmaceuticals (INDV) Interest Coverage Ratio (2024 - 2026) Analysis & Trends
Indivior Pharmaceuticals' Interest Coverage Ratio history runs 3 years deep, the most recent figure standing at 9.79 for Q1 2026.
- In Q1 2026, Interest Coverage Ratio rose 77.92% year-over-year to 9.79; the TTM figure through Mar 2026 stood at 23.79 (up 3590.89% YoY), while the FY2025 annual figure was 4.76, up 489.19% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 9.79, down from 13.5 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 13.5 in Q4 2025, with the low at 13.11 in Q2 2024.
- The 3-year median for Interest Coverage Ratio is 4.8 (2025), against an average of 4.35.
- Peak annual rise in Interest Coverage Ratio reached 281.52% in 2025, while the deepest fall reached 34.0% in 2025.
- Indivior Pharmaceuticals' Interest Coverage Ratio stood at 3.54 in 2024, then surged by 281.52% to 13.5 in 2025, then retreated by 27.51% to 9.79 in 2026.
- Business Quant data shows INDV's Interest Coverage Ratio at 9.79 in Q1 2026, 13.5 in Q4 2025, and 3.58 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -3.15 |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 114.07 |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 0.05 |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 52.24 |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 4.20 |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Indivior Pharmaceuticals | 4.54 Bn | 4.31 Bn | 294.00 Mn | 80.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.31 |
| Mar 31, 2026 | 9.79 |
| Dec 31, 2025 | 13.50 |
| Sep 30, 2025 | 3.58 |
| Jun 30, 2025 | 4.80 |
| Mar 31, 2025 | 5.50 |
| Dec 31, 2024 | 3.54 |
| Sep 30, 2024 | 3.18 |
| Jun 30, 2024 | -13.11 |
| Mar 31, 2024 | 8.33 |